SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea
· Delayed Price · Currency is KRW 110,200
-9,600 (-8.01%)
Mar 3, 2026, 3:30 PM KST
-3.33% (1Y)
| Market Cap | 8.63T |
| Revenue (ttm) | 675.41B |
| Net Income (ttm) | 320.47B |
| Shares Out | 78.31M |
| EPS (ttm) | 4,092.19 |
| PE Ratio | 26.93 |
| Forward PE | 32.56 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 356,512 |
| Average Volume | 275,863 |
| Open | 119,300 |
| Previous Close | 119,800 |
| Day's Range | 110,000 - 119,500 |
| 52-Week Range | 86,900 - 144,100 |
| Beta | 0.79 |
| RSI | 40.59 |
| Earnings Date | Feb 4, 2026 |